The amazing osteocyte.

PubWeight™: 5.32‹?› | Rank: Top 1%

🔗 View Article (PMC 3179345)

Published in J Bone Miner Res on February 01, 2011

Authors

Lynda F Bonewald1

Author Affiliations

1: Department of Oral Biology, University of Missouri-Kansas City, Kansas City, MO 64108-2784, USA. Bonewaldl@umkc.edu

Articles citing this

(truncated to the top 100)

Matrix-embedded cells control osteoclast formation. Nat Med (2011) 5.77

Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med (2011) 5.66

WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med (2013) 4.52

Cancer to bone: a fatal attraction. Nat Rev Cancer (2011) 4.08

Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol (2011) 3.51

Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. J Bone Miner Res (2012) 2.53

Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone. Proc Natl Acad Sci U S A (2015) 2.25

MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol (2012) 2.05

Update on Wnt signaling in bone cell biology and bone disease. Gene (2011) 2.03

The osteocyte: an endocrine cell ... and more. Endocr Rev (2013) 1.84

Suppression of autophagy in osteocytes mimics skeletal aging. J Biol Chem (2013) 1.80

Mechanical regulation of signaling pathways in bone. Gene (2012) 1.65

HDAC5 controls MEF2C-driven sclerostin expression in osteocytes. J Bone Miner Res (2015) 1.60

Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J Clin Endocrinol Metab (2012) 1.54

Dysapoptosis of osteoblasts and osteocytes increases cancellous bone formation but exaggerates cortical porosity with age. J Bone Miner Res (2014) 1.52

The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol (2013) 1.48

Tumor-induced pressure in the bone microenvironment causes osteocytes to promote the growth of prostate cancer bone metastases. Cancer Res (2015) 1.47

Estrogen and the skeleton. Trends Endocrinol Metab (2012) 1.46

Alcohol and bone: review of dose effects and mechanisms. Osteoporos Int (2011) 1.40

miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem (2012) 1.39

The mechanical consequences of load bearing in the equine third metacarpal across speed and gait: the nonuniform distributions of normal strain, shear strain, and strain energy density. FASEB J (2013) 1.39

Osteocyte control of osteoclastogenesis. Bone (2012) 1.36

Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo. J Bone Miner Res (2011) 1.35

Osteoblast lineage-specific effects of notch activation in the skeleton. Endocrinology (2012) 1.32

Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial. Osteoporos Int (2014) 1.29

Osteocyte RANKL: new insights into the control of bone remodeling. J Bone Miner Res (2012) 1.29

Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches. Nat Rev Endocrinol (2013) 1.23

Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. J Biol Chem (2013) 1.23

The relevance of mouse models for investigating age-related bone loss in humans. J Gerontol A Biol Sci Med Sci (2013) 1.23

Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance. J Bone Miner Res (2012) 1.22

Bone and skeletal muscle: neighbors with close ties. J Bone Miner Res (2013) 1.19

Wnt signaling in bone development and disease: making stronger bone with Wnts. Cold Spring Harb Perspect Biol (2012) 1.18

Bone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases. Cell Adh Migr (2012) 1.18

Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int (2012) 1.13

The skeleton as an endocrine organ. Nat Rev Rheumatol (2012) 1.13

Ligand binding and activation of PPARγ by Firemaster® 550: effects on adipogenesis and osteogenesis in vitro. Environ Health Perspect (2014) 1.12

Calcium response in osteocytic networks under steady and oscillatory fluid flow. Bone (2012) 1.11

Osteocyte regulation of bone mineral: a little give and take. Osteoporos Int (2012) 1.11

In vitro and in vivo approaches to study osteocyte biology. Bone (2012) 1.09

OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells. PLoS One (2013) 1.09

Osteocyte-driven bone remodeling. Calcif Tissue Int (2013) 1.08

Osteocytic network is more responsive in calcium signaling than osteoblastic network under fluid flow. J Bone Miner Res (2012) 1.08

Regulation of Wnt/β-catenin signaling within and from osteocytes. Bone (2013) 1.08

Miniplates and mini-implants: bone remodeling as their biological foundation. Dental Press J Orthod (2015) 1.07

Contributions of the host microenvironment to cancer-induced bone disease. Cancer Res (2014) 1.07

Forum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR workshop. J Bone Miner Res (2013) 1.06

Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin. Eur Cell Mater (2012) 1.06

Glucocorticoid dose determines osteocyte cell fate. FASEB J (2011) 1.06

Effects of PTH on osteocyte function. Bone (2012) 1.03

Conditional inactivation of noggin in the postnatal skeleton causes osteopenia. Endocrinology (2012) 1.01

Notch signaling in skeletal health and disease. Eur J Endocrinol (2013) 1.00

In situ intracellular calcium oscillations in osteocytes in intact mouse long bones under dynamic mechanical loading. FASEB J (2013) 1.00

Basic biology of skeletal aging: role of stress response pathways. J Gerontol A Biol Sci Med Sci (2013) 1.00

Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts. J Bone Miner Res (2013) 0.99

Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading. PLoS One (2012) 0.99

Vitamin D: calcium and bone homeostasis during evolution. Bonekey Rep (2014) 0.98

Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World J Stem Cells (2013) 0.98

Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. J Biol Chem (2013) 0.98

In vivo mechanical loading rapidly activates β-catenin signaling in osteocytes through a prostaglandin mediated mechanism. Bone (2015) 0.98

Osteoclasts: New Insights. Bone Res (2013) 0.97

Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients (2013) 0.96

A review of the efficacy and safety of denosumab in postmenopausal women with osteoporosis. Ther Adv Musculoskelet Dis (2011) 0.96

A novel specialized staging system for cancellous fracture healing, distinct from traditional healing pattern of diaphysis corticalfracture? Int J Clin Exp Med (2015) 0.96

Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin? PLoS One (2013) 0.95

Osteoblast-chondrocyte interactions in osteoarthritis. Curr Osteoporos Rep (2014) 0.95

FGF23 production by osteocytes. Pediatr Nephrol (2012) 0.93

Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes. PLoS One (2012) 0.93

Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int (2015) 0.92

Osteocyte-specific deletion of Fgfr1 suppresses FGF23. PLoS One (2014) 0.92

Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency. Bone (2014) 0.92

Connexin 43 channels are essential for normal bone structure and osteocyte viability. J Bone Miner Res (2015) 0.91

Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma. Cancer Res (2016) 0.91

Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? Osteoporos Int (2014) 0.90

For whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases. Bone (2012) 0.90

Forum on aging and skeletal health: summary of the proceedings of an ASBMR workshop. J Bone Miner Res (2011) 0.90

Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system. J Bone Miner Res (2014) 0.89

Load regulates bone formation and Sclerostin expression through a TGFβ-dependent mechanism. PLoS One (2013) 0.89

Effects of bioactive lipids and lipoproteins on bone. Trends Endocrinol Metab (2013) 0.89

From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD. Pediatr Nephrol (2015) 0.89

Role of Osteocyte-derived Insulin-Like Growth Factor I in Developmental Growth, Modeling, Remodeling, and Regeneration of the Bone. J Bone Metab (2014) 0.89

A review of osteocyte function and the emerging importance of sclerostin. J Bone Joint Surg Am (2014) 0.89

The multifaceted actions of PTHrP in skeletal metastasis. Future Oncol (2012) 0.89

Crosstalk between caveolin-1/extracellular signal-regulated kinase (ERK) and β-catenin survival pathways in osteocyte mechanotransduction. J Biol Chem (2013) 0.89

Skeletal adaptation to intramedullary pressure-induced interstitial fluid flow is enhanced in mice subjected to targeted osteocyte ablation. PLoS One (2012) 0.89

Vitamin D and gene networks in human osteoblasts. Front Physiol (2014) 0.89

Structural and mechanical repair of diffuse damage in cortical bone in vivo. J Bone Miner Res (2014) 0.89

Heat-shock-induced cellular responses to temperature elevations occurring during orthopaedic cutting. J R Soc Interface (2012) 0.88

Wnt signaling and osteoporosis. Maturitas (2014) 0.88

Spatiotemporal properties of intracellular calcium signaling in osteocytic and osteoblastic cell networks under fluid flow. Bone (2013) 0.88

Dairy in adulthood: from foods to nutrient interactions on bone and skeletal muscle health. J Am Coll Nutr (2013) 0.88

Integrin αv in the mechanical response of osteoblast lineage cells. Biochem Biophys Res Commun (2014) 0.87

Phenotypic characterization of osteoarthritic osteocytes from the sclerotic zones: a possible pathological role in subchondral bone sclerosis. Int J Biol Sci (2012) 0.87

Changes in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levels. J Bone Miner Res (2013) 0.87

The parathyroid hormone-regulated transcriptome in osteocytes: parallel actions with 1,25-dihydroxyvitamin D3 to oppose gene expression changes during differentiation and to promote mature cell function. Bone (2014) 0.87

Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells. Toxicology (2015) 0.87

Serum sclerostin is an independent predictor of mortality in hemodialysis patients. BMC Nephrol (2014) 0.86

The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice. Elife (2015) 0.86

Osteocytes remove and replace perilacunar mineral during reproductive cycles. Bone (2013) 0.86

Notch signaling in skeletal stem cells. Calcif Tissue Int (2013) 0.86

Emerging role of primary cilia as mechanosensors in osteocytes. Bone (2012) 0.86

Articles cited by this

(truncated to the top 100)

Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet (2006) 7.53

Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev (2000) 6.42

MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell (1999) 6.40

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet (2001) 5.72

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem (2005) 5.33

Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res (2008) 4.82

Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem (2007) 4.74

Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab (2007) 4.64

Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol (2007) 4.59

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med (2004) 3.88

A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech (1994) 3.76

Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res (2009) 3.69

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J (2005) 3.61

Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab (2006) 3.57

Osteocytes, mechanosensing and Wnt signaling. Bone (2008) 3.57

Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology (2005) 3.42

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res (2011) 3.25

Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One (2008) 2.96

SOST is a target gene for PTH in bone. Bone (2005) 2.94

Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol (2010) 2.85

Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol Biol Cell (2005) 2.75

Sensitivity of osteocytes to biomechanical stress in vitro. FASEB J (1995) 2.53

Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res (2005) 2.41

Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone (2004) 2.35

Buried alive: how osteoblasts become osteocytes. Dev Dyn (2006) 2.23

Mechanotransduction and strain amplification in osteocyte cell processes. Proc Natl Acad Sci U S A (2004) 2.16

Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone (1996) 2.11

Primary cilia mediate mechanosensing in bone cells by a calcium-independent mechanism. Proc Natl Acad Sci U S A (2007) 2.10

Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab (2000) 2.08

MLO-Y4 osteocyte-like cells support osteoclast formation and activation. J Bone Miner Res (2002) 2.01

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone (2009) 2.00

E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol (2006) 1.98

Femoral vein ligation increases bone mass in the hindlimb suspended rat. Bone (1999) 1.95

The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab (1997) 1.87

Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab (2010) 1.87

Osteocytes as dynamic multifunctional cells. Ann N Y Acad Sci (2007) 1.86

Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo. J Bone Miner Res (1996) 1.86

The production of nitric oxide and prostaglandin E(2) by primary bone cells is shear stress dependent. J Biomech (2001) 1.84

The P2X7 nucleotide receptor mediates skeletal mechanotransduction. J Biol Chem (2005) 1.81

Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. Am J Physiol Cell Physiol (2005) 1.70

Fluid shear-induced ATP secretion mediates prostaglandin release in MC3T3-E1 osteoblasts. J Bone Miner Res (2004) 1.69

Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression. J Biol Chem (2006) 1.68

Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo. J Bone Miner Res (2003) 1.66

Osteocytic osteolysis. Calcif Tissue Res (1969) 1.65

FGF-23: More than a regulator of renal phosphate handling? J Bone Miner Res (2010) 1.63

Mechanotransduction in bone: do bone cells act as sensors of fluid flow? FASEB J (1994) 1.57

Pulsating fluid flow increases nitric oxide (NO) synthesis by osteocytes but not periosteal fibroblasts--correlation with prostaglandin upregulation. Biochem Biophys Res Commun (1995) 1.51

Delineating bone's interstitial fluid pathway in vivo. Bone (2004) 1.51

Mechanosensation and Transduction in Osteocytes. Bonekey Osteovision (2006) 1.50

Osteocyte lacunae tissue strain in cortical bone. J Biomech (2005) 1.49

Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways. J Bone Miner Res (2010) 1.47

The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone. J Cell Sci (2004) 1.46

Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: similarities with mineralization of lamellar bone. Calcif Tissue Int (2006) 1.44

Early strain-related changes in enzyme activity in osteocytes following bone loading in vivo. J Bone Miner Res (1989) 1.43

Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation? J Bone Miner Res (2002) 1.40

Real-time measurement of solute transport within the lacunar-canalicular system of mechanically loaded bone: direct evidence for load-induced fluid flow. J Bone Miner Res (2011) 1.40

Roles of gap junctions and hemichannels in bone cell functions and in signal transmission of mechanical stress. Front Biosci (2007) 1.34

Activation of β-catenin signaling in MLO-Y4 osteocytic cells versus 2T3 osteoblastic cells by fluid flow shear stress and PGE2: Implications for the study of mechanosensation in bone. Bone (2010) 1.33

Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes. J Bone Miner Res (1999) 1.31

Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen. J Clin Invest (2000) 1.30

Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets. Calcif Tissue Int (1983) 1.30

Osteocyte apoptosis and control of bone resorption following ovariectomy in mice. Bone (2009) 1.30

Dendritic processes of osteocytes are mechanotransducers that induce the opening of hemichannels. Proc Natl Acad Sci U S A (2010) 1.30

Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res (2010) 1.29

Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp Cell Res (2004) 1.28

Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J Bone Miner Res (1998) 1.28

Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res (2008) 1.25

Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen. J Bone Miner Res (2006) 1.25

Prostaglandin promotion of osteocyte gap junction function through transcriptional regulation of connexin 43 by glycogen synthase kinase 3/beta-catenin signaling. Mol Cell Biol (2010) 1.24

Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem (2002) 1.22

Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis. Clin J Am Soc Nephrol (2010) 1.21

PARATHORMONE-INDUCED OSTEOLYSIS IN DOGS. A MICRORADIOGRAPHIC AND ALPHARADIOGRAPHIC SURVEY. J Bone Joint Surg Am (1964) 1.20

Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone. J Bone Miner Metab (2004) 1.18

Bone formation by osteocytes. Am J Physiol (1971) 1.17

Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival. Evidence for inside-out signaling leading to anoikis. J Biol Chem (2007) 1.15

Matrix mineralization and the differentiation of osteocyte-like cells in culture. J Bone Miner Res (1995) 1.15

Shorter, more frequent mechanical loading sessions enhance bone mass. Med Sci Sports Exerc (2002) 1.13

Osteocyte hypoxia: a novel mechanotransduction pathway. Am J Physiol (1999) 1.11

MEPE expression in osteocytes during orthodontic tooth movement. Arch Oral Biol (2007) 1.11

Skeletal strain and the functional significance of bone architecture. Calcif Tissue Int (1984) 1.10

Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts. J Bone Miner Res (2002) 1.08

Distinct responses of different populations of bone cells to mechanical stress. Endocrinology (1996) 1.07

FGF23 is mainly synthesized by osteocytes in the regularly distributed osteocytic lacunar canalicular system established after physiological bone remodeling. J Electron Microsc (Tokyo) (2009) 1.06

Bisphosphonate-induced, hemichannel-mediated, anti-apoptosis through the Src/ERK pathway: a gap junction-independent action of connexin43. Cell Commun Adhes (2001) 1.05

Quantitative evaluation on osteocyte canalicular density in human secondary osteons. Bone (1995) 1.02

Isolation and purification of osteocytes. J Bone Miner Res (1992) 1.00

Immunohistochemical investigations on the differentiation marker protein E11 in rat calvaria, calvaria cell culture and the osteoblastic cell line ROS 17/2.8. Histochem Cell Biol (1999) 0.99

Increased 3H-uridine levels in osteocytes following a single short period of dynamic bone loading in vivo. Calcif Tissue Int (1988) 0.97

The canalicular structure of compact bone in the rat at different ages. Microsc Microanal (2002) 0.96

Effects of hibernation on interradicular alveolar bone. J Dent Res (1977) 0.95

Effects of nanomechanical bone tissue properties on bone tissue strain: implications for osteocyte mechanotransduction. J Musculoskelet Neuronal Interact (2009) 0.95

Identification of osteocyte-selective proteins. Proteomics (2010) 0.93

Mature osteocytes behaviour in a repletion period: the occurrence of osteoplastic activity. Basic Appl Histochem (1983) 0.90

[Effect of space flight on rat skeletal bones (an optical light and electron microscopic study)]. Kosm Biol Aviakosm Med (1977) 0.90

Terminal differentiation of osteoblasts to osteocytes is accompanied by dramatic changes in the distribution of actin-binding proteins. J Bone Miner Res (2004) 0.89

Does blood pressure enhance solute transport in the bone lacunar-canalicular system? Bone (2010) 0.87

Immunohistochemical localization of the differentiation marker E11 in dental development of rats. Acta Histochem (1999) 0.85

Extracellular calcium causes the release of calcium from intracellular stores in chick osteocytes. Biochem Biophys Res Commun (1995) 0.85

Antagonistic interplay between mechanical forces and glucocorticoids in bone: a tale of kinases. J Cell Biochem (2010) 0.85

Emerging drugs for postmenopausal osteoporosis. Expert Opin Emerg Drugs (2009) 0.83